glp-1 receptor agonist type 1 diabetes trial liraglutide glp-1_analogs [TUSOM A System-Based Review on Effects

Bjerre Knudsen, L

Decreased appetite is an expected pharmacological effect rather than an adverse event, though the degree of appetite suppression can be more pronounced than some patients anticipate

Originally developed and positioned as treatments for type 2 diabetes, these agents are now equally associated with weight management, reshaping how clinicians, patients, and pharmacies understand metabolic disease

Retailers: The Walmart findings suggest that retailers could also see a reduction in the total amount of food purchased by customers, although other retailers, such as Kroger, expect this to be more of a change in the types of food purchased, rather than an overall reduction in basket size